Clinical Trials Insight: 700035343
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 14 Jan 2010
At a glance
- Drugs Influenza virus delta-NS1 vaccine (Primary)
- Indications Influenza A virus H5N1 subtype
- Focus Adverse reactions; Therapeutic Use
- Sponsors AVIR Green Hills Biotechnology
- 14 Jan 2010 Status changed from recruiting to active, no longer recruiting.
- 13 Jan 2010 Data from this trial is expected in quarter 1 2010, as reported by AVIR Green Hills Biotechnology.
- 16 Jul 2008 New trial record.